Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Chemosensitizing Role of Metformin in Anti-Cancer Therapy
Zhimin Tang, Nan Tang, Shanshan Jiang, et al.
Anti-Cancer Agents in Medicinal Chemistry (2020) Vol. 21, Iss. 8, pp. 949-962
Closed Access | Times Cited: 18

Showing 18 citing articles:

Targeting monocarboxylate transporters (MCTs) in cancer: How close are we to the clinics?
Mamta Singh, Julieta Afonso, Dolly Sharma, et al.
Seminars in Cancer Biology (2023) Vol. 90, pp. 1-14
Closed Access | Times Cited: 59
Synergistic anticancer effects of doxorubicin and metformin combination therapy: A systematic review
Fereshtehsadat Jalali, Fatemeh Fakhari, Afrah Sepehr, et al.
Translational Oncology (2024) Vol. 45, pp. 101946-101946
Open Access | Times Cited: 6
Metformin and glioma: Targeting metabolic dysregulation for enhanced therapeutic outcomes
Haneen A. Basheer, Nadeem Salman, R. Abdullah, et al.
Translational Oncology (2025) Vol. 53, pp. 102323-102323
Closed Access
Synergistic anti-cancer effects of metformin and cisplatin on YD-9 oral squamous carcinoma cells via AMPK pathway
Pavan Pradhan, Young‐Hee Lee, Sungil Jang, et al.
Journal of Applied Oral Science (2025) Vol. 33
Open Access
Metformin anticancer: Reverses tumor hypoxia induced by bevacizumab and reduces the expression of cancer stem cell markers CD44/CD117 in human ovarian cancer SKOV3 cells
Yuanchun Fan, Huimin Cheng, Yueping Liu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 17
Metformin induces autophagy of cisplatin-resistant human gastric cancer cells in addition to apoptosis
Chih-Wun Fang, Jai‐Sing Yang, Jo‐Hua Chiang, et al.
Biomedicine (2023) Vol. 13, Iss. 2
Open Access | Times Cited: 9
Natural products as a source of new anticancer chemotypes
Francesco Melfi, Simone Carradori, Noemi Mencarelli, et al.
Expert Opinion on Therapeutic Patents (2023) Vol. 33, Iss. 11, pp. 721-744
Closed Access | Times Cited: 9
Repurposing Metformin in hematologic tumor: State of art
Min Hu, Yan Chen, Tao Ma, et al.
Current Problems in Cancer (2023) Vol. 47, Iss. 4, pp. 100972-100972
Open Access | Times Cited: 7
Biotinylated curcumin as a novel chemosensitizer enhances naphthalimide-induced autophagic cell death in breast cancer cells
Chenwen Shao, Jian Wu, Siqi Han, et al.
European Journal of Medicinal Chemistry (2021) Vol. 228, pp. 114029-114029
Closed Access | Times Cited: 13
The Potential Therapeutic Impact of Metformin in Glioblastoma Multiforme
Mehdi Sanati, Samaneh Aminyavari, Hamid Mollazadeh, et al.
Current Medicinal Chemistry (2022) Vol. 30, Iss. 7, pp. 857-877
Closed Access | Times Cited: 9
Changes in the Sensitivity of MCF-7 and MCF-7/DX Breast Cancer Cells to Cytostatic in the Presence of Metformin
Justyna Płonka, Luiza Żyrek, Małgorzata Latocha
Molecules (2024) Vol. 29, Iss. 15, pp. 3531-3531
Open Access | Times Cited: 1
The signature of extracellular vesicles in hypoxic breast cancer and their therapeutic engineering
Beiqing Zhu, Kehao Xiang, Tanghua Li, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Metformin Alleviates Epirubicin-Induced Endothelial Impairment by Restoring Mitochondrial Homeostasis
Qi Sun, Huiling Jia, Shuo Cheng, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 343-343
Open Access | Times Cited: 6
pH-responsive self-assembling peptides potentiate therapeutic efficacy via prolonged drug retention and immunomodulation
Shan Peng, Xiaomeng Yuan, Hongjie Li, et al.
Materials & Design (2024) Vol. 241, pp. 112893-112893
Open Access
The Metformin Immunoregulatory Actions in Tumor Suppression and Normal Tissues Protection
Jitendra Gupta, Abduladheem Turki Jalil, Zahraa Hamzaa Abd Alzahraa, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 33, pp. 5370-5396
Closed Access | Times Cited: 1
Metformin: A potential adjunct for treatment of systemic mastocytosis
Joseph H. Butterfield, Kathleen R. Bartemes
Journal of Allergy and Clinical Immunology Global (2023) Vol. 3, Iss. 1, pp. 100186-100186
Open Access
Metformin Intake Suppresses The Degree of Liver Metastasis From Colorectal Cancer In Diabetic Patients But Does Not Improve Their Prognosis
Akira Saito, Joji Kitayama, Hisanaga Horie, et al.
Research Square (Research Square) (2021)
Open Access
Metformin Intake Suppresses the Degree of Liver Metastasis From Colorectal Cancer in Diabetic Patients but Does not Improve their Prognosis
Akira Saito, Joji Kitayama, Hisanaga Horie, et al.
Journal of Surgery and Research (2021) Vol. 04, Iss. 04
Open Access
Page 1

Scroll to top